Combination of immunoadsorption and CD20 antibody therapy in a patient with mixed connective tissue disease.
نویسندگان
چکیده
or discontinue AZA/MTX had been made at consultant level, despite previous reports that transaminase elevations may be found in myositis [2–4] and other muscle diseases [4–6]. Transaminases are important intracellular components of metabolic function in many cells, including those of muscle, and elevated ALT levels may reflect transaminase leakage into the bloodstream, due to myofibrillar damage, in a manner analogous to lactate dehydrogenase and creatine phosphokinase (CPK) leakage [7]. The purpose of this ethically approved study was to examine the relationship between serum ALT and CPK levels in myositis patients, in order to establish whether ALT levels could be predicted from CPK levels. From the Salford adult-onset myositis (disease onset after 18 yr of age) database, 61 patients were identified with probable or definite myositis, according to Bohan and Peter criteria [8, 9]. Of these patients, 18 had DM, 22 PM and 21 PM as part of a connective tissue disease overlap. In a retrospective analysis of these 61 patients' data, 208 occasions were identified when their ALT, CPK and alkaline phosphatase (ALP) levels were measured together in the same laboratory, and where all the results were available. As this study was retrospective, the results of other hepatic transaminases or-glutamyl transferase were not available , so ALP was used instead as a surrogate 'other' marker of hepatic function. Correlations between the log-converted values of ALT, CPK and ALP were made using linear regression analysis and scatter-graph plots were constructed. The results demonstrated a strong correlation between serum CPK and ALT An equation of the line can be derived from the Fig. 1, describing the correlation between log CPK/ALT values [log CPK ¼ 1.47 Â (log ALT þ 0.18)], and allows prediction of ALT levels from measured CPK levels. For instance, a myositis-induced CPK rise to double the upper normal limit, i.e. to 390 U/l (log value 2.59), would be associated with an ALT level still just within the laboratory normal upper limit, of 50 U/l (log value 1.7), while a myositis-induced ALT rise to 100 U/l would not be expected until CPK levels had risen to around 1000 U/l. That not all rheumatologists appreciate that ALT rises occur in active myositis was the stimulus for this brief study. The knowledge that CPK and ALT correlate so well and that ALT levels can be predicted from CPK levels should reassure those treating myositis patients that ALT elevations are probably of muscle …
منابع مشابه
B cell Therapy to Treat an Axonal Neuropathy in Mixed Connective Tissue Disease
The B cell is a vital contributor to humoral immunity. The B cell-specific antigen CD20 is expressed during B cell development, starting at the pre-B cell level and persists through B cell differentiation, but is lost during terminal differentiation to plasma cells. Rituximab is a monoclonal antibody that destroys both normal and malignant B cells that have CD20 on their surfaces and is ther...
متن کاملA Case and Literature Review of Normal Pressure Hydrocephalus in Mixed Connective Tissue Disease
Normal Pressure hydrocephalus (NPH) is characterized by gait apraxia, urinary incontinence, and dementia. Mixed connective tissue disease (MCTD) is an autoimmune connective tissue disease that has never been reported to cause NPH. Our patient was a 67-year man with a one-year history of gradual worsening gait and balance, urinary urgency with urge incontinence and decreased short-term memory. P...
متن کاملClinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).
BACKGROUND Epidermolysis bullosa acquisita (EBA) is an autoimmune bullous disorder with mucocutaneous involvement, skin fragility, and tendency to scarring. The mechanobullous form of EBA has a chronic relapsing course and is difficult to treat. We describe herein the therapeutic response of 2 patients with recalcitrant mechanobullous EBA to combined treatment with immunoadsorption and rituxima...
متن کاملConstruction and cloning of a recombinant expression vector containing human Cd20 Gene for antibody therapy in Non-Hodgkin Lymphoma
ABSTRACT Introduction: Non-Hodgkin lymphoma (NHL) is a cancer that starts in lymphocytes. The main treatment for NHL is chemotherapy and radiation. Today immunotherapy is a promising therapeutic approach in the treatment of a variety cancers which is high specific unlike previous methods. Antibodies do not penetrate effectively into tumore tissues because of their large size. Whe...
متن کاملSuccessful treatment of type B insulin resistance with mixed connective tissue disease by pulse glucocorticoids and cyclophosphamide
Type B insulin resistance syndrome is a very rare condition caused by autoantibodies against the insulin receptor. We report the successful treatment of a patient with refractory type B insulin resistance with pulse glucocorticoids and cyclophosphamide. The medical record of a patient with type B insulin resistance was reviewed. A 36-year-old Chinese woman presented with menopause, weight loss ...
متن کاملSuccessful Etanercept Therapy for Refractory Sacroiliitis in a Patient with Ankylosing Spondylitis and Mixed Connective Tissue Disease
The concurrence of ankylosing spondylitis (AS) in a patient with mixed connective tissue disease (MCTD) is rarely described in the literature. Significant and sustained efficacy with tumor necrosis factor (TNF)-alpha blockers has been demonstrated in AS patients. However, evidence to date has revealed associated side effects, including antinuclear antibody induction and development of a lupus-l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Rheumatology
دوره 45 4 شماره
صفحات -
تاریخ انتشار 2006